SKKY Partners, co-founded by Kim Kardashian and Jay Sammons, has made a significant minority investment in luxury skincare brand 111Skin to enhance its direct-to-consumer strategy and expand its international presence.
Information on the Target
111Skin is a luxury skincare brand that combines medical science with premium skincare, featuring innovative products such as cryotherapy-inspired de-puffing sheet masks and its best-selling Repair Serum, which includes a proprietary complex. Founded in 2022, the brand has established a loyal customer base and has gained notable popularity among high-profile admirers, including Kim Kardashian.
The brand's products are widely available through luxury retailers and exclusive partnerships with established hospitality groups like Four Seasons and Mandarin Oriental. In 2023, 111Skin reported revenues of £20.3 million ($24.9 million), with a significant portion of its sales coming from international markets.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The skincare industry in the UK has experienced substantial growth in recent years, driven by increasing consumer demand for high-quality and effective products. The rise in awareness of skincare benefits and the influence of social med
Similar Deals
SWIF Maven Equity Finance → Tom Parker Creamery
2024
NPIF II - Maven Equity Finance → CRL Foods
2023
Wind Point Partners → Assisi Pet Care Group Limited
2023
SKKY Partners
invested in
111Skin
in 2023
in a Growth Equity & Expansion Capital deal
Disclosed details
Revenue: $25M